Euflexxa generic name
Euflexxa
Published by
Last Updated On October 17, 2024

Euflexxa Generic Name – About Sodium Hyaluronate

Oct 11, 2024

Osteoarthritis is a global health concern affecting over 500 million people worldwide. It is the most common form of arthritis and causes joint pain and stiffness, particularly the knees. Many patients use viscosupplements like hyaluronic acid injections to manage these symptoms and improve joint function.

One such treatment is Euflexxa, which is known generically as sodium hyaluronate. This injectable therapy mimics the body’s natural joint fluid, providing lubrication and cushioning to relieve osteoarthritis-related pain. The key ingredient, sodium hyaluronate, is crucial in easing joint discomfort and restoring mobility.

In this article, we will explore the benefits of sodium hyaluronate, how it works in Euflexxa, and why it’s an effective option for managing osteoarthritis symptoms.

Key Takeaways

  • Euflexxa is a viscosupplement used to treat knee pain from osteoarthritis, with sodium hyaluronate as its key ingredient.
  • Sodium hyaluronate acts as a lubricant and cushion for the knee joint, helping to reduce pain and improve mobility.
  • This injectable therapy mimics the body’s natural joint fluid, providing long-term relief for osteoarthritis symptoms, typically lasting for several months.
  • Euflexxa is a non-steroidal treatment option, making it safer for long-term use compared to corticosteroids, with fewer associated side effects.
Buy EUFLEXXA®
EUFLEXXA®

$ 205.00
Add To Cart
+
Buy ORTHOVISC®
ORTHOVISC®

$ 52.00
Add To Cart
+

About: Trusted by over 2,000+ global clients since 2014, Maylips has become a leading supplier of cosmetic, skincare, and orthopedic products for medical and aesthetic professionals. Maylips offers a wide range of authentic brand-name products at competitive wholesale prices, sourced from around the world. If you’re looking to buy Euflexxa online, contact our sales team for guidance.

What is Euflexxa and Its Generic Name?

Euflexxa is an injectable treatment designed to relieve knee pain caused by osteoarthritis. Its active ingredient, sodium hyaluronate, is a form of hyaluronic acid that mimics the body’s natural joint fluid. By acting as a cushion and lubricant in the knee, it helps reduce discomfort and improve mobility, especially in patients who haven’t found relief with more straightforward treatments like oral medications or physical therapy.

Administered directly into the knee joint, this gel-like solution provides targeted relief for those suffering from joint pain. While side effects may occur, Euflexxa is a vital option for patients seeking alternatives to surgery or long-term medication.

Properties of Sodium Hyaluronate

Sodium hyaluronate is a polysaccharide composed of repeating units of D-glucuronic acid and N-acetyl-D-glucosamine. This polymer forms a linear chain that can vary significantly in molecular weight, influencing its functional properties. This structure makes it ideal for use in viscosupplementation treatments like Euflexxa injections, where the goal is to restore joint fluid and improve mobility.

One of the key advantages of sodium hyaluronate is its viscosity—its thick, gel-like consistency helps to reduce friction between bones, allowing smoother movement. This property makes it an effective lubricant for joints affected by osteoarthritis, relieving pain and stiffness.

Another important characteristic is its biocompatibility. Since sodium hyaluronate closely resembles the body’s natural joint fluid, it is generally well-tolerated by patients, minimizing the risk of adverse reactions.

Function of Sodium Hyaluronate as a Viscosupplement

Sodium hyaluronate plays a crucial role in joint health by acting as a cushion and lubricant, especially for those with osteoarthritis. In treatments like Euflexxa injections, this active ingredient mimics the body’s natural joint fluid, compensating for the decreased lubrication and cushioning often occurring in osteoarthritic joints.

  • Mechanism of Action: Sodium hyaluronate helps joints move smoothly by reducing friction between bones, which in turn reduces pain and stiffness.
  • Restoring Lubrication and Cushioning: The injection helps restore the lost lubrication in the joint, providing the necessary cushioning to absorb shocks and facilitate better movement.
  • Managing Osteoarthritis Symptoms: For patients who haven’t found relief with standard pain medications, Euflexxa injections offer an effective alternative. The 1% sodium hyaluronate solution improves mobility and reduces discomfort, allowing patients to resume daily activities with greater ease.

Importance of Sodium Hyaluronate in Joint Health

For osteoarthritis patients, sodium hyaluronate injections help support joint function and improve mobility.

  • Pain Relief: Sodium hyaluronate significantly reduces the pain associated with osteoarthritis by cushioning the joints and minimizing friction.
  • Improved Mobility: The enhanced lubrication provided by sodium hyaluronate injections allows smoother joint movement, making daily activities more manageable.
  • Cartilage Protection: By reducing wear and tear on the joints, sodium hyaluronate helps protect the cartilage from further damage, which is vital for maintaining long-term joint health.
  • Fewer Side Effects: Compared to corticosteroids, sodium hyaluronate is a safer option for long-term use, with fewer associated side effects.

Long-term Impact on Osteoarthritis Management

When considering viscosupplements like Euflexxa vs Orthovisc, it’s important to recognize that while both use sodium hyaluronate to relieve knee pain, they may differ in their specific formulations and duration of effectiveness. Euflexxa, for instance, offers a formulation designed to mimic natural joint fluid, providing lasting relief for several months and helping patients maintain an active lifestyle.

Over time, treatments like Euflexxa can significantly enhance osteoarthritis management by restoring joint lubrication, reducing pain, and improving mobility. Unlike corticosteroids, Euflexxa is steroid-free, making it a safer option for long-term care without the common side effects of steroid-based treatments. This makes it ideal for those seeking lasting relief from osteoarthritis symptoms.

Conclusion

Euflexxa’s key ingredient, sodium hyaluronate, serves as a vital cushion in the knee joint, helping to reduce pain caused by wear and tear from osteoarthritis. This treatment is generally safe for most patients and integrates well into long-term care plans.

By providing lasting pain relief and improving joint mobility, sodium hyaluronate proves to be an effective solution for managing osteoarthritis symptoms, offering renewed hope for those seeking relief from knee pain.

FAQs

1. What is sodium hyaluronate, and how does it work in Euflexxa?

Sodium hyaluronate is a naturally occurring substance found in the joints. In Euflexxa, it mimics the body’s synovial fluid, lubricating the knee joint to reduce pain and improve mobility.

2. How often do I need Euflexxa injections?

Euflexxa is typically administered in three injections, one week apart. The effects can last up to six months, but this varies by patient.

3. Can Euflexxa help if other treatments haven’t worked?

Yes, Euflexxa is often recommended for patients who have not found relief from other treatments like oral pain medications or physical therapy.

Need help, additional info, or customized deals?

Talk with our sales representative.

Book a Meeting

References

GBD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Rheumatology. 21 August 2023. doi: 10.1016/S2665-9913(23)00163-7

Altman RD, Rosen JE, Bloch DA, Hatoum HT, Korner P. A Double-Blind, randomized, Saline-Controlled study of the efficacy and safety of EUFLEXXA® for treatment of painful osteoarthritis of the knee, with an Open-Label Safety extension (The FLEXX Trial). Seminars in Arthritis and Rheumatism. 2009;39(1):1-9. doi:10.1016/j.semarthrit.2009.04.001